Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
- PMID: 19194464
- DOI: 10.1038/leu.2009.3
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
Abstract
Natural killer (NK)-cell malignancies are among the most aggressive lymphoid neoplasms with very poor prognosis. We performed array comparative genomic hybridization analysis on a number of NK cell lines and primary tumors to gain better understanding of the pathogenesis and tumor biology of these malignancies. We also obtained transcriptional profiles of genes residing in these regions and compared them with normal and activated NK cells. Only 30-50% of the genes residing in the gained or deleted regions showed corresponding increased or decreased expression. However, many of the upregulated genes in regions of gain are functionally important for the proliferation and growth of the neoplastic population. Genes downregulated in regions of loss included many transcription factors or repressors, tumor suppressors or negative regulators of the cell cycle. The minimal common region of deletion in 6q21 included three known genes (PRDM1, ATG5 and AIM1) showing generally low expression. Mutations resulting in truncated PRDM1 and changes in conserved amino-acid sequences of AIM1 were detected. Highly methylated CpG islands 5' of PRDM1 and AIM1 correlated with low expression of the transcripts. Reversal of methylation by Decitabine induced expression of PRDM1 and cell death. In conclusion, we have shown a general tumor-promoting effect of genetic alterations and have identified PRDM1 as the most likely _target gene in del6q21. ATG5, an essential gene for autophagy and AIM1, a gene implicated in melanoma, may also participate in the functional abnormalities.
Similar articles
-
Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses.Blood. 2011 Sep 22;118(12):3195-204. doi: 10.1182/blood-2011-04-346890. Epub 2011 Jun 20. Blood. 2011. PMID: 21690554
-
PRDM1 is a tumor suppressor gene in natural killer cell malignancies.Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20119-24. doi: 10.1073/pnas.1115128108. Epub 2011 Dec 5. Proc Natl Acad Sci U S A. 2011. PMID: 22143801 Free PMC article.
-
Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a _target of PRDM1.Tumour Biol. 2017 May;39(5):1010428317701648. doi: 10.1177/1010428317701648. Tumour Biol. 2017. PMID: 28468592
-
Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.Leukemia. 1998 Jun;12(6):845-59. doi: 10.1038/sj.leu.2401043. Leukemia. 1998. PMID: 9639410 Review.
-
PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.Leuk Lymphoma. 2015 May;56(5):1223-8. doi: 10.3109/10428194.2014.953155. Epub 2014 Oct 7. Leuk Lymphoma. 2015. PMID: 25115512 Review.
Cited by
-
EBV and the Pathogenesis of NK/T Cell Lymphoma.Cancers (Basel). 2021 Mar 19;13(6):1414. doi: 10.3390/cancers13061414. Cancers (Basel). 2021. PMID: 33808787 Free PMC article. Review.
-
DNMT1 and AIM1 Imprinting in human placenta revealed through a genome-wide screen for allele-specific DNA methylation.BMC Genomics. 2013 Oct 5;14:685. doi: 10.1186/1471-2164-14-685. BMC Genomics. 2013. PMID: 24094292 Free PMC article.
-
JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.Oncol Rep. 2019 Jun;41(6):3219-3232. doi: 10.3892/or.2019.7112. Epub 2019 Apr 12. Oncol Rep. 2019. PMID: 31002364 Free PMC article.
-
Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.Haematologica. 2018 Feb;103(2):278-287. doi: 10.3324/haematol.2017.180430. Epub 2017 Nov 2. Haematologica. 2018. PMID: 29097495 Free PMC article.
-
AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.J Invest Dermatol. 2012 Jun;132(6):1689-97. doi: 10.1038/jid.2012.36. Epub 2012 Mar 8. J Invest Dermatol. 2012. PMID: 22402438 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous